NCT03651349 To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03626012 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT03613571 A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE2
NCT03613038 A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria Status COMPLETED Phase NA
NCT03579017 Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study Status COMPLETED Phase N/A
NCT03578796 Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03573466 Presymptomatic Neuromuscular Junction Defects and Compensatory Mechanisms in ALS Status UNKNOWN Phase NA
NCT03560661 Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase N/A
NCT03537807 Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) Status NO_LONGER_AVAILABLE Phase N/A
NCT03536962 Multidisciplinary Follow-up of Patients With Amyotrophic Lateral Sclerosis Status UNKNOWN Phase N/A
NCT03520517 Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS Status COMPLETED Phase PHASE1
NCT03519880 A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects Status TERMINATED Phase NA
NCT03516994 Reducing Disparities in the Quality of Advance Care Planning for Older Adults Status COMPLETED Phase NA
NCT03505021 Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS Status COMPLETED Phase PHASE3